Latest News:  

Company

Tribute Pharmaceuticals is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada.

Product Portfolio

Tribute Pharmaceuticals targets several therapeutic areas in Canada, but has a particular interest in products for the treatment of pain, dermatology, urology, endocrinology and specialty care. Tribute Pharmaceuticals also sells Uracyst® and NeoVisc® internationally through a number of strategic partnerships.

Investors

Tribute Pharmaceuticals Announces Acquisition of Medical Futures Inc., a Canadian Specialty Pharmaceutical Company

06/17/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., is pleased to announce that it has acquired Medical Futures Inc. ("MFI") in a transaction valued at $25 million.